Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06322602

Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors

Led by Mayo Clinic · Updated on 2026-03-03

20

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Mayo Clinic

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the use of an Ommaya reservoir implanted during a biopsy to collect biomarkers over time in patients with brain tumors. Biomarkers are measurable signs that indicate the presence or severity of the disease. This approach aims to provide a minimally invasive way to monitor tumor growth and response to treatment by collecting cerebrospinal fluid (CSF) samples without repeated spinal taps, addressing the challenge of limited long-term CSF access in current studies. The study involves placing an Ommaya reservoir, a small device implanted under the scalp, during a standard biopsy procedure. Patients will have CSF extracted through this reservoir at multiple points during the study. Optionally, lumbar punctures may also be performed. Participants will undergo CT or MRI scans to monitor the tumor. The primary focus is to assess the feasibility and utility of this reservoir placement over a period of up to five years. Participants will be involved in regular procedures to collect CSF samples and undergo imaging tests such as CT or MRI. Researchers will monitor how well the reservoir placement works and how useful the collected biomarkers are for tracking the tumor. The study includes safety monitoring and aims to follow participants for up to five years to gather long-term data. The total duration of participation varies depending on individual treatment and follow-up schedules.

CONDITIONS

Brief Title

Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical and radiographic evidence suggesting a diagnosis of a brain tumor
  • Planned biopsy for suspected or previously diagnosed brain tumor as part of routine clinical care at Mayo Clinic
  • Willingness to provide informed consent
  • Willingness to have the Ommaya reservoir sampled on at least two future occasions
  • Willingness to have cerebrospinal fluid banked through the neuro-oncology biorepository (requires a separate signature)
Not Eligible

You will not qualify if you...

  • Adults lacking capacity to consent
  • Vulnerable populations including pregnant women, prisoners, and individuals under 18 years old
  • Patients not appropriate candidates for biopsy due to current or past medical history or uncontrolled illness
  • Prior history of any wound infection
  • Patients deemed by the surgeon as not optimal candidates for Ommaya reservoir placement due to surgical anatomy, immunosuppression, elevated risk of wound infection, diabetes, smoking history, morbid obesity, or other concerns

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Day of biopsy and immediate recovery period

Participants undergo Ommaya reservoir placement at the time of their standard of care biopsy.

1 surgical visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants have cerebrospinal fluid collected through the Ommaya reservoir on at least two future occasions. Optional lumbar puncture and imaging with CT or MRI are also performed during this time to monitor biomarkers.

Multiple visits for CSF collection and imaging as scheduled

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Similar Trials

A Prospective Comparative Study of a Novel Gadolinium-Weight...

Brain Neoplasms

Actively Recruiting

1 location

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paed...

Haematological Malignancy

Actively Recruiting

27 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here